Biogen, Inc. (BIIB)
193.33
-7.85
(-3.90%)
USD |
NASDAQ |
Feb 09, 15:26
Biogen Price : 193.33 for Feb. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1052.77 |
| Merck & Co., Inc. | 117.19 |
| AbbVie, Inc. | 222.76 |
| Stoke Therapeutics, Inc. | 31.92 |
| Alnylam Pharmaceuticals, Inc. | 320.49 |
Price Related Metrics
| PE Ratio | 21.96 |
| PS Ratio | 2.977 |
| Price to Book Value | 1.554 |
| Price to Free Cash Flow | 14.41 |
| Earnings Yield | 4.55% |
| Market Cap | 28.36B |
| Operating PE Ratio | 11.78 |
| Normalized PE Ratio | 16.66 |